(19)
(11) EP 1 390 048 A2

(12)

(88) Date of publication A3:
21.11.2002

(43) Date of publication:
25.02.2004 Bulletin 2004/09

(21) Application number: 02712385.0

(22) Date of filing: 15.02.2002
(51) International Patent Classification (IPC)7: A61K 31/726, A61K 31/727, A61K 31/728, A61K 31/737, A61K 47/28, A61K 47/44, A61P 7/02, A61P 7/04
(86) International application number:
PCT/JP2002/001299
(87) International publication number:
WO 2002/064148 (22.08.2002 Gazette 2002/34)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 16.02.2001 JP 2001040661
28.09.2001 JP 2001299632

(71) Applicants:
  • Shimizu Pharmaceutical Co., Ltd.
    Shizuoka-shi, Shizuoka 424-0911 (JP)
  • BioSerenTach Co., Ltd.
    Kyoto-shi, Kyoto 600-8040 (JP)

(72) Inventors:
  • TAKADA, Kanji,618-2, Gokoumachidori
    Kyoto-shi,Kyoto 600-8040 (JP)
  • MATSUURA, Akihiro
    Haibara-gun, Shizuoka 428-0022 (JP)
  • MORI, Saori
    Fujinomiya-shi, Shizuoka 418-0067 (JP)

(74) Representative: Albrecht, Thomas, Dr. 
Kraus & Weisert,Thomas-Wimmer-Ring 15
80539 München
80539 München (DE)

   


(54) ORAL FORMULATIONS CONTAINING MUCOPOLYSACCHARIDE FOR SMALL INTESTINE DELIVERY AND THEIR USE IN THE TREATMENT CIRCULATORY DISORDERS